series-c-plus
Stage
2
Investors
About
Perceive Bio develops novel therapeutic candidates that protect vision by targeting retinal degeneration and neuroprotection, leveraging decades of academic research into protective biology with lead programs addressing dry age-related macular degeneration and other causes of irreversible blindness.
Explore Perceive Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.